Skip to Content
Skip to Search

Global

Change location

Healthcare professionals Contact us Search

GSK logo linking to the homepage

Behind the science magazine
Back to main Behind the science magazine

Behind the science magazine
Close menu
Company
Back to main Company

Company

Purpose, strategy and culture

Outstanding people

Company Outstanding people

Working together

My GSK story

Innovating together 2022

Innovating together 2021

GSK at a glance

History and heritage

Board of directors and leadership team

Board information

Governance

Company Governance

Committees

Shareholders

Sarbanes-Oxley Act 2002

Compliance

Policy positions

Codes, standards and reports
FEATURED SECTION Our purpose, strategy and culture FEATURED SECTION Outstanding people
Close menu
Innovation
Back to main Innovation

Innovation

Research and development approach

Pipeline

Therapeutic areas

Innovation Therapeutic areas

Infectious diseases

HIV

Respiratory/immunology

Oncology

Opportunity-driven

Technologies

Clinical trials at GSK

Innovation Clinical trials at GSK

Provision of unlicensed medicines for unmet medical needs

Data transparency

Diversity in clinical trials

Partnering with GSK

Innovation Partnering with GSK

Supported studies

R&D locations
SPOTLIGHT ON Behind the science magazine Featured section Partnering with GSK
Close menu
Products
Back to main Products

Products

Our product areas

Products A-Z
SPOTLIGHT ON Innovation FEATURED WEBSITE GSKPro
Close menu
Responsibility
Back to main Responsibility

Responsibility

Access

Global health and health security

Responsibility Global health and health security

Global health

Health security

Using our science for global health

Improving access to healthcare

Environment

Responsibility Environment

Climate

Water

Materials and waste

Biodiversity

Diversity, equity and inclusion

Ethical standards

Responsibility Ethical standards

Working with third parties

Public policy and patient advocacy

Human rights

Use of animals

Engaging with healthcare professionals

Product governance

Charitable Investments

ESG resources

Responsibility ESG resources

ESG reports archive
FEATURED SECTION Diversity equity and inclusion SPOTLIGHT ON Our policy positions
Close menu
Investors
Back to main Investors

Investors

Why invest in GSK?

Quarterly results

Financial reports

Investors Financial reports

Annual Report 2022

Corporate reports archive

Environmental, social and governance

Speeches and presentations

Events calendar

Dividend and share price

Investors Dividend and share price

GSK share price

Share price calculators (GBp/USD)

Dividend calculators (GBp/USD)

Dividend calendar

Analyst consensus

Shareholder information

Investors Shareholder information

Manage your shares

Annual General Meeting

General Meeting

Annual Governance Meeting

Corporate sponsored nominee service

Our ADR programme

Asset reunification - ProSearch

Share scam alert

Privacy notice for ordinary shareholders

FAQs

Stock exchange announcements

Investors Stock exchange announcements

London (RNS)

London (RNS) inside information

New York (SEC)

Sign up for announcements

Corporate actions

Investors Corporate actions

Consumer Healthcare Demerger

Consumer Healthcare Joint Venture

Agreement to acquire TESARO

Debt investors

Investor contacts
SPOTLIGHT ON Press releases SPOTLIGHT ON Our pipeline
Close menu
Media
Back to main Media

Media

Press releases

Media contacts

Conferences

Media library

Our response to the situation in Ukraine

Our response to COVID-19

Our social media

RSS feeds
FEATURED SECTION Behind the science magazine SPOTLIGHT ON Conferences
Close menu
Careers
Back to main Careers

Careers

Search jobs

Featured careers

Careers Featured careers

A career in Data

Life at GSK

Careers Life at GSK

What’s your angle?

Experienced professionals

Careers Experienced professionals

Business Operations

Engineering at GSK

Manufacturing and supply

Marketing and sales

Research and development

Experienced professionals Research and development

Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS)

Genomic sciences

Technology

Early talent

Careers Early talent

Kickstart your career

Apprentice programmes

Work experience, placements and internships

Future leaders graduate programme

Early talent Future leaders graduate programme

Business operations

Engineering

Manufacturing Operations, Quality & Supply Chain

Marketing and sales

Research and development

Technology

Post graduate opportunities

Our global and regional hubs

How we hire

Careers How we hire

Frequently asked questions

Fraudulent internet recruitment activities
FEATURED SECTION Outstanding people FEATURED SECTION Diversity equity and inclusion
Close menu
Healthcare professionals
Contact us

Home
Investors
Speeches and presentations
Core Earnings Reporting

01 December 2011

Core Earnings Reporting

Simon Dingemans, Chief Financial Officer discusses the methodology GSK will use for its core earnings reporting to begin with effect from Q1 2012.

This is our global website, intended for visitors seeking information on GSK's worldwide business. Our market sites can be reached by visiting our location selector.

© 2001-2023 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.

GSK plc. Registered in England and Wales No. 3888792.

Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.

Modern Slavery Act statement 2022 (PDF - 189.7KB)

GSK websites
Locations selector
Social media directory
GSKPro for healthcare professionals
GSK study register
Supplier website
ViiV Healthcare

Quick links
Behind the science magazine
Company
Innovation
Products
Responsibility
Investors
Media
Careers

Get in touch
Partnerships
Report a possible side effect
GSK Speak up
Follow us on:
- facebook
- twitter
- youtube
- linkedin
- instagram
- rss

Accessibility
Terms of use
Cookie policy
Privacy notice
Sitemap